Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes
Authors:
- Reginald ClaytonRCReginald Clayton
- Asa OhagenAOAsa Ohagen
- Francois NicolFNFrancois Nicol
- Alfred M. Del VecchioAVAlfred M. Del Vecchio
- Tim H.M. JonckersTJTim H.M. Jonckers
- Olivia GoethalsOGOlivia Goethals
- Marnix Van LoockMLMarnix Van Loock
- Lieve MichielsLMLieve Michiels
- John GrigsbyJGJohn Grigsby
- Zheng XuZXZheng Xu
- Yuan Peng ZhangYZYuan Peng Zhang
- Lester L. GutshallLGLester L. Gutshall
- 1 November 2009
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 84 (2) , 142-149
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Endocytic mechanisms for targeted drug delivery☆Advanced Drug Delivery Reviews, 2007
- Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of ActionJournal of Virology, 2006
- Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptorsNature Biotechnology, 2005
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- THE NEXT GENERATION OF LIPOSOME DELIVERY SYSTEMS: RECENT EXPERIENCE WITH TUMOR-TARGETED, STERICALLY-STABILIZED IMMUNOLIPOSOMES AND ACTIVE-LOADING GRADIENTSJournal of Liposome Research, 2002
- Targeting of Liposomes to HIV-1-Infected Cells by Peptides Derived from the CD4 ReceptorBiochemical and Biophysical Research Communications, 1996
- Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG)Biochimica et Biophysica Acta (BBA) - Biomembranes, 1994
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990